Related Experiment Video
Updated: May 30, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
Published on: July 30, 2020
Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death
V Ratushny1, H B Pathak, N Beeharry
1Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Abstract:
Increased activity of SRC family kinases promotes tumor invasion and metastasis, and overexpression of the mitotic regulator Aurora kinase A (AURKA) drives tumor aneuploidy and chromosomal instability. These functions nominate SRC and AURKA as valuable therapeutic targets for cancer, and inhibitors for SRC and Aurora kinases are now being used in the clinic. In this study, we demonstrate potent synergy between multiple inhibitors of Aurora and SRC kinases in ovarian and colorectal cancer cell lines, but not in normal ovarian epithelial cell lines. Combination of Aurora and SRC inhibitors selectively killed cells that have undergone a preceding aberrant mitosis, and was associated with a postmitotic reattachment defect, and selective removal of aneuploid cell populations. Combined inhibition of Aurora kinase and SRC potentiated dasatinib-dependent loss of activated (Y(416)-phosphorylated) SRC. SRC and AURKA share a common interaction partner, NEDD9, which serves as a scaffolding protein with activities in cell attachment and mitotic control, suggesting SRC and AURKA might interact directly. In vitro, we observed physical interaction and mutual cross-phosphorylation between SRC and AURKA that enhanced SRC kinase activity. Together, these findings suggest that combination of SRC and Aurora-targeting inhibitors in the clinic may be a productive strategy.
Insights
Combining Aurora and SRC kinase inhibitors shows potent synergy in killing cancer cells, particularly those with mitotic defects. This targeted approach selectively removes aneuploid cells, offering a promising new cancer therapy strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- SRC family kinases (SFKs) drive tumor invasion and metastasis.
- Aurora kinase A (AURKA) overexpression causes aneuploidy and chromosomal instability.
- Both SRC and AURKA are validated therapeutic targets in cancer treatment.
Purpose of the Study:
- To investigate the synergistic effects of combining Aurora and SRC kinase inhibitors.
- To determine the mechanisms underlying the synergy between these inhibitors.
- To evaluate the potential of this combination therapy in ovarian and colorectal cancers.
Main Methods:
- Utilized ovarian and colorectal cancer cell lines and normal ovarian epithelial cells.
- Administered combinations of Aurora and SRC kinase inhibitors.
- Assessed cell viability, mitotic progression, and aneuploidy.
- Investigated protein interactions and phosphorylation events between SRC and AURKA.
Main Results:
- Demonstrated potent synergy between Aurora and SRC inhibitors in cancer cell lines, but not normal cells.
- Observed selective killing of cells with aberrant mitosis, postmitotic reattachment defects, and aneuploidy.
- Showed that combined inhibition potentiated dasatinib-induced loss of activated SRC.
- Confirmed physical interaction and mutual cross-phosphorylation between SRC and AURKA, enhancing SRC activity.
Conclusions:
- Combination therapy targeting SRC and Aurora kinases exhibits potent anti-cancer effects.
- The synergy is linked to the selective elimination of aneuploid cells and cells with mitotic defects.
- Combined inhibition of SRC and AURKA represents a promising therapeutic strategy for cancer treatment.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
07:14Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations
Published on: September 20, 2019
Related Concept Videos
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Anaphase Promoting Complex
Attachment of Sister Chromatids
Meiosis II
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...